(Q48225859)

9 February 2018

title

Aminergic systems in Alzheimer's disease and Parkinson's disease. (English)

1 reference

9 February 2018

1 reference

1 reference

D'Amato RJ

1

1 reference

9 February 2018

Zweig RM

2

1 reference

9 February 2018

Whitehouse PJ

3

1 reference

9 February 2018

Wenk GL

4

1 reference

9 February 2018

Singer HS

5

1 reference

9 February 2018

Mayeux R

6

1 reference

9 February 2018

Price DL

7

1 reference

9 February 2018

Snyder SH

8

1 reference

9 February 2018

publication date

1 August 1987

1 reference

9 February 2018

published in

Annals of Neurology

1 reference

9 February 2018

volume

22

1 reference

9 February 2018

page(s)

229-236

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410220207

Alzheimer's neurofibrillary changes. A topographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410220207

Altered serotonin metabolism in depressed patients with parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410220207

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410220207

Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410220207

Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410220207

21 January 2018

Identifiers

DOI

10.1002/ANA.410220207

1 reference

9 February 2018

PubMed ID

3477996

1 reference

9 February 2018